The AACE/ACE obesity guidelines classify GLP-1 receptor agonist therapy as a first-line pharmacologic intervention for BMI above 30, or BMI above 27 with weight-related comorbidities, [26] and PCOS, GDM history, and post-bariatric regain all meet that threshold in most patients
For example, Diet Coke is generally considered compatible with keto, vegan, and gluten-free diets
Beyond the Peptide: Holistic Support for Lasting Lifestyle Transformation Lasting results require more than medication
Southeast Asia region : DG 12 (Pharmacy intelligence), DG 15 (People-centred care), and DG 19 (Patient safety)
Evaluate the evidence for their combined effects and articulate the biological mechanisms, shared and distinct, that could underlie synergy or augmentation
Once your best medication is identified through genetic insight, the pen-versus-vial choice becomes purely a matter of lifestyle preference, not guesswork about medication efficacy